SUGAMMADEX ARX sugammadex (as sodium) 500 mg/5 mL solution for injection vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

sugammadex sodium, Quantity: 554 mg (Equivalent: sugammadex, Qty 500 mg)

Available from:

Accelagen Pty Ltd

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; water for injections

Administration route:

Intravenous

Units in package:

10 x 5 mL vials

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Sugammadex ARX is indicated for the reversal of neuromuscular blockade induced by rocuronium or vecuronium.

Product summary:

Visual Identification: A clear, colourless to slightly yellow solution free from visible particles.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Registered

Authorization date:

2022-06-08